{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:56Z","timestamp":1791357416110,"version":"4.3.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["13T-012"],"award-info":[{"award-number":["13T-012"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jad.2017.11.081","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T19:45:16Z","timestamp":1510861516000},"page":"787-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders"],"prefix":"10.1016","volume":"227","author":[{"given":"Michael Cronquist","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jad.2017.11.081_bib1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1176\/ajp.2006.163.9.1569","article-title":"Job performance deficits due to depression","volume":"163","author":"Adler","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2017.11.081_bib2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4088\/JCP.v67n0914","article-title":"What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?","volume":"67","author":"Bandelow","year":"2006","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2017.11.081_bib3","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Bang-Andersen","year":"2011","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.jad.2017.11.081_bib4","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/1871527313666141130203823","article-title":"Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review","volume":"13","author":"Bortolato","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.jad.2017.11.081_bib5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1176\/appi.ajp.2010.09101406","article-title":"Prediction of real-world functional disability in chronic mental disorders: a comparison of schizophrenia and bipolar disorder","volume":"167","author":"Bowie","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2017.11.081_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1176\/appi.ajp.163.3.418","article-title":"Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms","volume":"163","author":"Bowie","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2017.11.081_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-0447.2008.01285.x","article-title":"Mediators of the association between depression and role functioning","volume":"118","author":"Buist-Bouwman","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.jad.2017.11.081_bib8","first-page":"28","article-title":"The clinical global impressions scale. Applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)."},{"issue":"11","key":"10.1016\/j.jad.2017.11.081_bib9","doi-asserted-by":"crossref","first-page":"e1001547","DOI":"10.1371\/journal.pmed.1001547","article-title":"burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010","volume":"10","author":"Ferrari","year":"2013","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib10","doi-asserted-by":"crossref","first-page":"e90311","DOI":"10.1371\/journal.pone.0090311","article-title":"The impact of individual depressive symptoms on impairment of psychosocial functioning","volume":"9","author":"Fried","year":"2014","journal-title":"PLoS One 2014"},{"issue":"4","key":"10.1016\/j.jad.2017.11.081_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2010.10030414","article-title":"Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia","volume":"168","author":"Green","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4088\/JCP.14m09298","article-title":"The economic burden of adults with major depressive disorder in the United States (2005 and 2010)","volume":"76","author":"Greenberg","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/jnp.2006.18.2.217","article-title":"Neurocognition in depression: patients on and off medication versus healthy comparison subjects","volume":"18","author":"Gualtieri","year":"2006","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jad.2017.11.081_bib14","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4088\/JCP.v69n0712","article-title":"The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials","volume":"69","author":"Gualtieri","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/YIC.0b013e32834c2488","article-title":"Assessing the relationship between functional impairment\/recovery and depression severity: a pooled analysis","volume":"27","author":"Guico-Pabia","year":"2012","journal-title":"Int Clin. Psychopharmacol."},{"issue":"213","key":"10.1016\/j.jad.2017.11.081_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2017.02.014","article-title":"Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder","volume":"15","author":"Harvey","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jad.2017.11.081_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/occmed\/kqr020","article-title":"Depression and work performance: an ecological study using web-based screening","volume":"61","author":"Harvey","year":"2011","journal-title":"Occup. Med."},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archpsyc.1995.03950130011002","article-title":"Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses","volume":"52","author":"Hays","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Issue Suppl_1","key":"10.1016\/j.jad.2017.11.081_bib19","first-page":"28","article-title":"Impact of vortioxetine on functional capacity in MDD patients with subjective cognitive dysfunction: a post-hoc analysis of the University of California San Diego performance-based skills assessment","volume":"19","author":"Jacobson","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.psychres.2005.11.011","article-title":"Neurocognitive deficits and disability in major depressive disorder","volume":"145","author":"Jaeger","year":"2006","journal-title":"Psychiatry Res."},{"issue":"1\u20132","key":"10.1016\/j.jad.2017.11.081_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jad.2007.06.014","article-title":"Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders","volume":"108","author":"Judd","year":"2008","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.jad.2017.11.081_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/YIC.0b013e3283542457","article-title":"A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder","volume":"27","author":"Katona","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"23","key":"10.1016\/j.jad.2017.11.081_bib23","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity survey replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jad.2017.11.081_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00019442-200108000-00011","article-title":"Executive dysfunction and disability in elderly patients with major depression","volume":"9","author":"Kiosses","year":"2001","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/104012371502700209","article-title":"Canadian network for mood and anxiety treatments (CANMAT) consensus recommendations for functional outcomes in major depressive disorder","volume":"27","author":"Lam","year":"2015","journal-title":"Ann. Clin. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.jad.2017.11.081_bib26","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.jad.2011.03.046","article-title":"Clinical effectiveness: the importance of psychosocial functioning outcomes","volume":"132","author":"Lam","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2017.11.081_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2010.03.021","article-title":"Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change","volume":"119","author":"Leifker","year":"2010","journal-title":"Schizophr. Res."},{"issue":"8","key":"10.1016\/j.jad.2017.11.081_bib28","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"22","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2\u20133","key":"10.1016\/j.jad.2017.11.081_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.schres.2011.07.022","article-title":"Sensitivity and specificity of the UCSD performance-based skills assessment (UPSA-B) for identifying functional milestones in schizophrenia","volume":"132","author":"Mausbach","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-5618.2009.00787.x","article-title":"Relationship of the brief UCSD performance-based skills assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder","volume":"12","author":"Mausbach","year":"2010","journal-title":"Bipolar Disord."},{"issue":"6","key":"10.1016\/j.jad.2017.11.081_bib31","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/schbul\/sbm014","article-title":"Development of a brief scale of everyday functioning in persons with serious mental illness","volume":"33","author":"Mausbach","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/JCP.16m10744","article-title":"Efficacy of vortioxetine on cognitive functioning in working patients with major depressive disorder","volume":"78","author":"McIntyre","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2017.11.081_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s40263-015-0263-x","article-title":"The prevalence, measurement, and treatment of the cognitive dimension\/domain in major depressive disorder","volume":"29","author":"McIntyre","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2017.11.081_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.comppsych.2014.08.051","article-title":"The impact of cognitive impairment on perceived workforce performance: results from the International mood disorders collaborative project","volume":"56","author":"McIntyre","year":"2015","journal-title":"Compr. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2017.11.081_bib35","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jad.2017.11.081_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cpr.2009.01.005","article-title":"The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research","volume":"29","author":"McKnight","year":"2009","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jad.2017.11.081_bib37","unstructured":"Merikle E., Zhong W., Olsen C.K., Perez V., Jacobson W., 2017. UCSD performance-based skill assessment (UPSA): psychometric evaluation of the communication and financial skill domains. Presented at: Annual Meeting of American Society of Clinical Psychopharmacology. CitationURL: \u3008https:\/\/pmg.joynadmin.org\/documents\/1005\/591f221d68ed3f9b06cce90a.pdf\u3009 (last accessed 25 September 2017)."},{"issue":"1\u20133","key":"10.1016\/j.jad.2017.11.081_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2015.02.014","article-title":"UPSA-M: feasibility and initial validity of a mobile application of the UCSD performance-based skills assessment","volume":"164","author":"Moore","year":"2015","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.jad.2017.11.081_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.schres.2012.12.028","article-title":"Initial validation of a computerized version of the UCSD performance-based skills assessment (C-UPSA) for assessing functioning in schizophrenia","volume":"144","author":"Moore","year":"2013","journal-title":"Schizophr. Res."},{"issue":"9590","key":"10.1016\/j.jad.2017.11.081_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the world health surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","article-title":"The economic cost of brain disorders in Europe","volume":"19","author":"Olesen","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/oxfordjournals.schbul.a006870","article-title":"UCSD performance-based skills assessment: development of a new measure of everyday functioning for severely mentally ill adults","volume":"27","author":"Patterson","year":"2001","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.jad.2017.11.081_bib43","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2017.11.081_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1017\/S003329170800411X","article-title":"Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis","volume":"39","author":"Reppermund","year":"2009","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.jad.2017.11.081_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eurpsy.2009.02.007","article-title":"Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study","volume":"25","author":"Romera","year":"2010","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2017.11.081_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2014.07.001","article-title":"Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data","volume":"145","author":"Sanchez","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jad.2017.11.081_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/YIC.0b013e328341bb5f","article-title":"Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale","volume":"26","author":"Sheehan","year":"2011","journal-title":"Int Clin. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.jad.2017.11.081_bib48","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1989.03430070062031","article-title":"The functioning and well-being of depressed patients. results from the Medical outcomes study","volume":"262","author":"Wells","year":"1989","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jad.2017.11.081_bib49","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1017\/S0033291708003620","article-title":"The relationship between cognitive function and clinical and functional outcomes in major depressive disorder","volume":"39","author":"Withall","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2017.11.081_bib50","unstructured":"World Health Organisation, 2017. Depression - fact sheet. \u3008http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/\u3009 (Accessed 25 September 2017)."},{"issue":"4","key":"10.1016\/j.jad.2017.11.081_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jval.2010.11.006","article-title":"Impact of depression on work productivity and its improvement after outpatient treatment with antidepressants","volume":"14","author":"Woo","year":"2011","journal-title":"Value Health"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717320049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717320049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:28:51Z","timestamp":1759022931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717320049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"alternative-id":["S0165032717320049"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.11.081","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vortioxetine improves symptomatic and functional outcomes in major depressive disorder: A novel dual outcome measure in depressive disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.11.081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}